title: Hepatic gene expression changes in mice associated with prolonged sublethal microcystin exposure.
abstract: Microcystin-LR (MCLR) is an acute hepatotoxicant and suspected carcinogen. Previous chronic studies have individually described hepatic morphologic changes, or alterations in the cytoskeleton, cell signaling or redox pathways. The objective of this study was to characterize chronic effects of MCLR in wild-type mice utilizing gene array analysis, morphology, and plasma chemistries. MCLR was given daily for up to 28 days. RNA from the 28-day study was hybridized onto mouse genechip arrays. RNA from 4 hours, 24 hours, 4 days, 1 day, and 28 days for selected genes was processed for quantitative-PCR. Increases in plasma hepatic enzyme activities and decreases in total protein, albumin and glucose concentrations were identified in MCLR-treated groups at 14 and 28 days. Histologically, marked hepatokaryomegaly was identified in the 14-day MCLR group with the addition of giant cells at 28 days. Major gene transcript changes were identified in the actin organization, cell cycle, apoptotic, cellular redox, cell signaling, albumin metabolism, and glucose homeostasis pathways, and the organic anion transport polypeptide system. Using toxicogenomics, we have identified key molecular pathways involved in chronic sublethal MCLR exposure in wild-type mice, genes participating in those critical pathways and related them to cellular and morphologic alterations seen in this and other studies.
authors.affiliation: Department of Veterinary Pathobiology, Purdue University, Indiana 47907, USA. shawn.clark@bms.com
authors.forename: Shawn P
authors.initials: SP
authors.lastname: Clark
authors.forename: Myrtle A
authors.initials: MA
authors.lastname: Davis
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Ryan
authors.forename: George H
authors.initials: GH
authors.lastname: Searfoss
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Hooser
mesh_terms: D000818:Animals; D001774:Blood Chemical Analysis; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics* / Q000473:pathology*; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects*; D016158:Genes, p53 / Q000235:genetics / Q000502:physiology; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008387:Marine Toxins; D051379:Mice; D018345:Mice, Knockout; D052998:Microcystins / Q000633:toxicity*; D020411:Oligonucleotide Array Sequence Analysis; D009929:Organ Size / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D043922:Toxicogenetics
chemical_list: D002273:Carcinogens; D018076:DNA, Complementary; D008387:Marine Toxins; D052998:Microcystins; D012313:RNA; C057862:cyanoginosin LR